CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Immunomedics, Inc. Company Snapshot
Immunomedics, Inc. operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immunomedics with three other pharmaceutical manufacturers in North America: Pediapharm Inc of Canada (2016 sales of 3.75 million Canadian Dollars [US$2.82 million] ), Pluristem Therapeutics Incorporation. ($2.85 million of which 100% was Stem Cells Expansion), and Procyon Corporation ($3.45 million ).

Sales Analysis. During the year ended June of 2016, sales at Immunomedics were $3.23 million. This is a sharp decrease of 42.8% versus 2015, when the company's sales were $5.65 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Immunomedics, Inc.
  Stock Performance Chart for Immunomedics, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2016): 3.24
(Figures in U.S. Dollars)
1 Week -6.6%   13 Weeks 45.3%  
4 Weeks 18.2%   52 Weeks 14.5%  
 
Immunomedics, Inc. Key Data:
  Ticker: IMMU Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 3,233,247
(Year Ending Jan 2017).
Employees: 131
  Currency: U.S. Dollars Market Cap: 310,854,850
  Fiscal Yr Ends: June Shares Outstanding: 95,942,855
  Share Type: Common Closely Held Shares: 6,340,205
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.